Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.
2.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
[PubMed - indexed for MEDLINE]
3.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.

PMID:
23074393
[PubMed]
Free PMC Article
4.

Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.

Adams S, Baum RP, Stuckensen T, Bitter K, Hör G.

Eur J Nucl Med. 1998 Sep;25(9):1255-60.

PMID:
9724374
[PubMed - indexed for MEDLINE]
5.

Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.

Satoh Y, Ichikawa T, Motosugi U, Kimura K, Sou H, Sano K, Araki T.

AJR Am J Roentgenol. 2011 Feb;196(2):447-53. doi: 10.2214/AJR.10.4687.

PMID:
21257899
[PubMed - indexed for MEDLINE]
6.

Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.

Schmidt S, Dunet V, Koehli M, Montemurro M, Meuli R, Prior JO.

Acta Radiol. 2013 Oct;54(8):837-42. doi: 10.1177/0284185113485732. Epub 2013 May 9.

PMID:
23761549
[PubMed - indexed for MEDLINE]
7.

Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC.

Heusch P, Sproll C, Buchbender C, Rieser E, Terjung J, Antke C, Boeck I, Macht S, Scherer A, Antoch G, Heusner TA, Handschel J.

Clin Oral Investig. 2014 Apr;18(3):969-78. doi: 10.1007/s00784-013-1050-z. Epub 2013 Jul 27.

PMID:
23892450
[PubMed - in process]
8.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
9.

Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J.

Eur Radiol. 2012 Dec;22(12):2859-67. doi: 10.1007/s00330-012-2542-y. Epub 2012 Jul 9.

PMID:
22772365
[PubMed - indexed for MEDLINE]
10.

Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix.

Olsen JR, Esthappan J, DeWees T, Narra VR, Dehdashti F, Siegel BA, Schwarz JK, Grigsby PW.

J Magn Reson Imaging. 2013 Feb;37(2):431-4. doi: 10.1002/jmri.23830. Epub 2012 Sep 28.

PMID:
23023940
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.

Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S.

Eur J Radiol. 2012 Jan;81(1):178-82. doi: 10.1016/j.ejrad.2010.09.001. Epub 2010 Oct 6.

PMID:
20932700
[PubMed - indexed for MEDLINE]
12.

Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.

Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, Bockisch A, Forsting M, Lauenstein T, Antoch G, Stahl A.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1077-86. doi: 10.1007/s00259-010-1399-z. Epub 2010 Mar 4.

PMID:
20204355
[PubMed - indexed for MEDLINE]
13.

Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.

Basu S, Li G, Bural G, Alavi A.

Acta Radiol. 2009 Mar;50(2):201-4. doi: 10.1080/02841850802620689.

PMID:
19089692
[PubMed - indexed for MEDLINE]
14.

Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.

Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):200-8. doi: 10.1007/s00259-008-0936-5. Epub 2008 Sep 9.

PMID:
18779960
[PubMed - indexed for MEDLINE]
15.

Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.

Takenaka D, Ohno Y, Matsumoto K, Aoyama N, Onishi Y, Koyama H, Nogami M, Yoshikawa T, Matsumoto S, Sugimura K.

J Magn Reson Imaging. 2009 Aug;30(2):298-308. doi: 10.1002/jmri.21858.

PMID:
19629984
[PubMed - indexed for MEDLINE]
16.

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V.

Eur Radiol. 2014 Apr;24(4):889-901. doi: 10.1007/s00330-013-3083-8. Epub 2013 Dec 11.

PMID:
24322510
[PubMed - in process]
17.

Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.

PMID:
23074392
[PubMed]
Free PMC Article
18.

Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.

Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, Higuchi T, Amanuma M, Endo K.

Ann Nucl Med. 2008 Jun;22(5):395-401. doi: 10.1007/s12149-008-0128-1. Epub 2008 Jul 4.

PMID:
18600417
[PubMed - indexed for MEDLINE]
19.

Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucose-positron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease.

Xing XW, Zhang JT, Zhu F, Ma L, Yin DY, Jia WQ, Huang XS, Pu CQ, Lang SY, Yu SY.

J Clin Neurosci. 2012 Oct;19(10):1354-7. doi: 10.1016/j.jocn.2011.11.035. Epub 2012 Jul 12.

PMID:
22795494
[PubMed - indexed for MEDLINE]
20.

Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.

Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y.

J Nucl Med. 2003 Feb;44(2):198-206.

PMID:
12571209
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk